(Q45063600)

9 December 2017

title

Stroke prevention in atrial fibrillation: physicians' attitudes to anticoagulation in older people (English)

1 reference

9 December 2017

1 reference

1 reference

Vasishta S

1

1 reference

9 December 2017

Toor F

series ordinal

2

1 reference

9 December 2017

Johansen A

series ordinal

3

1 reference

9 December 2017

Hasan M

series ordinal

4

1 reference

9 December 2017

publication date

1 November 2001

1 reference

Archives of Gerontology and Geriatrics

9 December 2017

published in

1 reference

9 December 2017

volume

33

1 reference

9 December 2017

issue

3

1 reference

9 December 2017

page(s)

219-226

1 reference

Survey of use of anticoagulation in patients with atrial fibrillation

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900184-4

7 January 2021

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900184-4

7 January 2021

Stroke Prevention in Atrial Fibrillation II Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900184-4

7 January 2021

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900184-4

7 January 2021

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900184-4

7 January 2021

ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900184-4

7 January 2021

Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900184-4

7 January 2021

Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900184-4

7 January 2021

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900184-4

7 January 2021

Final Consensus Statement of the Royal College of Physicians of Edinburgh Consensus Conference on Atrial Fibrillation in Hospital and General Practice, 3-4 September 1998

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900184-4

7 January 2021

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900184-4

7 January 2021

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900184-4

7 January 2021

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2801%2900184-4

7 January 2021

10.1016/S0167-4943(01)00184-4

Identifiers

DOI

1 reference

9 December 2017

1 reference